Unlocking NRF2 Research for Future Clinical Therapies
Thirty years since the discovery of NRF2
Cellular Mechanisms, Disease Modeling and Clinical Approaches to NRF2 Therapeutics
Building bridges between academy and industry around NRF2-based therapeutics
Translating NRF2 research into clinical practice
From Physiology to Pathology
Translating NRF2 research from bed to bench,
Knowing each other during the scientific meeting of COST Action CA20121.
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
Grant Holder: Universidad Autónoma de Madrid
Start of Action: 19 October, 2021
End of Action: 18 October, 2025
CSO approval date: 25 May 2021
Action email: info@benbedphar.org
© 2022 BenBedPhar | Design by Tuinbit Group
